Root Financial Partners
SRPT icon

Root Financial Partners’s Sarepta Therapeutics SRPT Stock Holding History

Root Financial Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$875 Buy
+48
New +$898 ﹤0.01% 3008
2026
Q2 		– Sell
-6
Closed -$131 – 2805
2026
Q1 		$131 Sell
6
-4
-40% -$77 ﹤0.01% 3233
2025
Q4 		$215 Buy
10
+3
+43% +$63 ﹤0.01% 2290
2025
Q3 		$135 Buy
+7
New +$125 ﹤0.01% 2226

Other funds holding SRPT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return

Root Financial Partners's SRPT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Sarepta Therapeutics (SRPT) in Q3 2026: 48 shares worth $875. The stake represents ﹤0.01% of the portfolio and ranks #3008 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in SRPT as recently as Q1 2026.

Root Financial Partners first reported a position in SRPT in Q3 2025 and has held it in 4 quarters since. 159 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.

  • Root Financial Partners held 48 shares of Sarepta Therapeutics worth $875 as of Q3 2026.
  • Sarepta Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3008 holding.
  • Root Financial Partners first reported a position in Sarepta Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 159 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.